December 07, 2010
There's no bigger booster of life sciences than Cheryl Reicin. Cheryl's corporate and securities practice focuses on biotech, medical devices and health information and services companies. She represents private equity and venture capital funds and investment banks that fund these companies.
Cheryl's client list in Canada, the United States and Israel can number up to 50 small and large corporations at any given time. Yet she admits to having a warm spot for emerging companies.
In an exclusive interview with BioTuesdays.com, Cheryl discusses her interest in biotech, how she divides her time between her practice in New York and Toronto, and many issues relevant to growing biotech companies.
To read the full article, click here.